Facebook
X

Phone: (843) 449-1010 | 823 82nd Parkway, Suite B, Myrtle Beach, SC 29572

Home
About Us
Staff
Current Trials
Patient Info
Testimonials
In The News
- In The News
Contact
Search
Menu Menu

Blog - Latest News

You are here: Home1 / In The News2 / Uncategorized3 / Intravesical rAd–IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin–Refractory or R...

Click here to view article

August 25, 2017/in Uncategorized/by CURC

Share this entry

Share on Facebook
Share on X
Share on X
Share on WhatsApp
Share on Pinterest
Share on LinkedIn
Share on Tumblr
Share on Vk
Share on Reddit
Share by Mail

https://carolinaurologicresearchcenter.com/wp-content/uploads/8.25-Intravescial.jpg 250 300 CURC /wp-content/uploads/logo-1.png CURC2017-08-25 08:29:482017-08-25 08:29:48Intravesical rAd–IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin–Refractory or Relapsed Non–Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. By Dr. Neal Shore

Current Happenings

START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center
Final Version: Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy
The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer
Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer
Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now
In the Era of Treatment Intensification for Prostate Cancer, Why Are Some Living in the Past?

Carolina Urologic Research Center
823 82nd Parkway, Suite B
Myrtle Beach, SC 29572

Phone: (843) 839-1679
Fax: (843) 286-0119

Email:
info@curcmb.com

Directions

Recent Happenings

START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center
Final Version: Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy
The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer
Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs

Our Affiliates

Facebook
X

Pathological Information Needed From Radical Prostatectomy Specimen for Locally...

Novel Gene Therapy Shows Three-Fold Improvement in Recurrence-Free Survival...

Scroll to top

Contact

Recent Happenings

Our Affiliates